EcoDrugPlus

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSPLAG00000010788
Gene Symbol: LOC106942810
3 Cross references
203 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSPLAG00000011000
Gene Symbol: MTOR
1 Cross references
161 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSPLAG00000001890
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSPLAG00000019670
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase

Ensembl ID : ENSPLAG00000000132
Gene Symbol: LOC106934486
2 Cross references
215 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSPLAG00000005428
Gene Symbol: MTNR1AA
1 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSPLAG00000010549
Gene Symbol: MME
3 Cross references
224 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSPLAG00000001857
Gene Symbol: LOC106950589
3 Cross references
211 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSPLAG00000023926
Gene Symbol: METAP2
4 Cross references
220 Possible Orthologues:

Mineralocorticoid Receptor-Like

Ensembl ID : ENSPLAG00000018402
Gene Symbol: LOC106962265
3 Cross references
206 Possible Orthologues:

Mineralocorticoid Receptor-Like

Ensembl ID : ENSPLAG00000013101
Gene Symbol: LOC106940898
3 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSPLAG00000020967
Gene Symbol: MAPK1
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).